I think this means the DSMB will unblind the results and take a peek to see which dosage PAR should use going forward. PAR won't have access to the results otherwise they will have to pay a Type I penalty, so PAR will have no say in it.
Ann: 2023 Annual Report and Appendix 4E, page-11
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $99.69M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 29.5¢ | 28.5¢ | $64.01K | 220.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 24323 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 12428 | 4 |
View Market Depth
| Last trade - 11.41am 08/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |